{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2", "angiotensin receptors", "coronavirus", "gene polymorphism", "single nucleotide polymorphism"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36231922", "DateCompleted": {"Year": "2022", "Month": "10", "Day": "17"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "02"}], "Language": ["eng"], "ELocationID": ["12622", "10.3390/ijerph191912622"], "Journal": {"ISSN": "1660-4601", "JournalIssue": {"Volume": "19", "Issue": "19", "PubDate": {"Year": "2022", "Month": "Oct", "Day": "02"}}, "Title": "International journal of environmental research and public health", "ISOAbbreviation": "Int J Environ Res Public Health"}, "ArticleTitle": "Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study.", "Abstract": {"AbstractText": ["The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2), has triggered an enormous scientific response. Many studies have focused on understanding the entry of the SARS-CoV-2 virus into the host cell. The angiotensin-converting enzyme-2 (ACE2) is recognized as the host receptor used by SARS-CoV-2 to enter its target cells. Recent studies suggest that ACE2 gene polymorphisms might be candidates for genetic susceptibility to SARS-CoV-2 infection. The aim of this study is to evaluate the influence of ACE2 polymorphisms on COVID-19 disease risk and severity. In our study, we confirmed that there is a statistically significant increased risk of a more severe disease course of SARS-CoV-2 infection associated with the need for hospitalization in intensive care for patients with specific polymorphisms of the ACE2 gene. The most significant correlation was found for variant ACE2 rs2285666 (AA allele, OR = 2.12, <i>p</i> = 0.0189) and ACE2 rs2074192 (TT allele, OR = 2.05, <i>p</i> = 0.0016), and for ACE2 rs4646174 (GG allele, OR = 1.93, <i>p</i> = 0.0016), ACE2 rs4646156 (TT allele OR = 1.71, <i>p</i> = 0.008) and ACE2 rs2158083 (TT allele OR = 1.84, <i>p</i> = 0.0025). In conclusion, our findings identify that certain ACE2 polymorphisms impact the severity of COVID-19 disease independently of other well-known risk factors."]}, "AuthorList": [{"Identifier": ["0000-0001-8141-7489"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery and Transplantology, Pomeranian Medical University, 70-111 Szczecin, Poland."}], "LastName": "Sienko", "ForeName": "Jerzy", "Initials": "J"}, {"Identifier": ["0000-0002-6711-9765"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, SUNY Downstate Medical Center, Brooklyn, NY 11023, USA."}], "LastName": "Marczak", "ForeName": "Izabela", "Initials": "I"}, {"Identifier": ["0000-0003-4870-0156"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery and Transplantology, Pomeranian Medical University, 70-111 Szczecin, Poland."}], "LastName": "Kotowski", "ForeName": "Maciej", "Initials": "M"}, {"Identifier": ["0000-0001-5455-8315"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibers and Medicinal Plants, 62-064 Plewiska, Poland."}], "LastName": "Bogacz", "ForeName": "Anna", "Initials": "A"}, {"Identifier": ["0000-0002-4742-5271"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery and Transplantology, Pomeranian Medical University, 70-111 Szczecin, Poland."}], "LastName": "Tejchman", "ForeName": "Karol", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases, and Cardiology, Pomeranian Medical University, 71-252 Szczecin, Poland."}], "LastName": "Sienko", "ForeName": "Magdalena", "Initials": "M"}, {"Identifier": ["0000-0001-8430-1369"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University, 70-111 Szczecin, Poland."}], "LastName": "Kotfis", "ForeName": "Katarzyna", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Observational Study", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Environ Res Public Health", "NlmUniqueID": "101238455", "ISSNLinking": "1660-4601"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiotensins"}, {"RegistryNumber": "EC 3.4.15.1", "NameOfSubstance": "Peptidyl-Dipeptidase A"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "ACE2 protein, human"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}], "MeshHeadingList": [{"QualifierName": ["genetics"], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["genetics"], "DescriptorName": "Angiotensins"}, {"QualifierName": ["epidemiology", "genetics"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Genetic Predisposition to Disease"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["genetics"], "DescriptorName": "Peptidyl-Dipeptidase A"}, {"QualifierName": ["genetics"], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z.W., Tian J.H., Pei Y.Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u2013269. doi: 10.1038/s41586-020-2008-3.", "ArticleIdList": ["10.1038/s41586-020-2008-3", "PMC7094943", "32015508"]}, {"Citation": "Coden M.E., Loffredo L.F., Abdala-Valencia H., Berdnikovs S. Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity. Viruses. 2021;13:1081. doi: 10.3390/v13061081.", "ArticleIdList": ["10.3390/v13061081", "PMC8226441", "34198852"]}, {"Citation": "Gaunt E.R., Hardie A., Claas E.C., Simmonds P., Templeton K.E. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J. Clin. Microbiol. 2010;48:2940\u20132947. doi: 10.1128/JCM.00636-10.", "ArticleIdList": ["10.1128/JCM.00636-10", "PMC2916580", "20554810"]}, {"Citation": "Hui D.S.C., Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect. Dis. Clin. N. Am. 2019;33:869\u2013889. doi: 10.1016/j.idc.2019.07.001.", "ArticleIdList": ["10.1016/j.idc.2019.07.001", "PMC7127569", "31668196"]}, {"Citation": "Nassar M.S., Bakhrebah M.A., Meo S.A., Alsuabeyl M.S., Zaher W.A. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Epidemiology, pathogenesis and clinical characteristics. Eur. Rev. Med. Pharmacol. Sci. 2018;22:4956\u20134961. doi: 10.26355/eurrev_201808_15635.", "ArticleIdList": ["10.26355/eurrev_201808_15635", "30070331"]}, {"Citation": "Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181\u2013192. doi: 10.1038/s41579-018-0118-9.", "ArticleIdList": ["10.1038/s41579-018-0118-9", "PMC7097006", "30531947"]}, {"Citation": "Weiss S.R., Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 2005;69:635\u2013664. doi: 10.1128/MMBR.69.4.635-664.2005.", "ArticleIdList": ["10.1128/MMBR.69.4.635-664.2005", "PMC1306801", "16339739"]}, {"Citation": "Scialo F., Daniele A., Amato F., Pastore L., Matera M.G., Cazzola M., Castaldo G., Bianco A. ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung. 2020;198:867\u2013877. doi: 10.1007/s00408-020-00408-4.", "ArticleIdList": ["10.1007/s00408-020-00408-4", "PMC7653219", "33170317"]}, {"Citation": "Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u2013273. doi: 10.1038/s41586-020-2012-7.", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631\u2013637. doi: 10.1002/path.1570.", "ArticleIdList": ["10.1002/path.1570", "PMC7167720", "15141377"]}, {"Citation": "Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., Li T., Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral. Sci. 2020;12:8. doi: 10.1038/s41368-020-0074-x.", "ArticleIdList": ["10.1038/s41368-020-0074-x", "PMC7039956", "32094336"]}, {"Citation": "Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 2020;14:185\u2013192. doi: 10.1007/s11684-020-0754-0.", "ArticleIdList": ["10.1007/s11684-020-0754-0", "PMC7088738", "32170560"]}, {"Citation": "Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000;275:33238\u201333243. doi: 10.1074/jbc.M002615200.", "ArticleIdList": ["10.1074/jbc.M002615200", "10924499"]}, {"Citation": "Voors A.A., Pinto Y.M., Buikema H., Urata H., Oosterga M., Rooks G., Grandjean J.G., Ganten D., van Gilst W.H. Dual pathway for angiotensin II formation in human internal mammary arteries. Br. J. Pharmacol. 1998;125:1028\u20131032. doi: 10.1038/sj.bjp.0702150.", "ArticleIdList": ["10.1038/sj.bjp.0702150", "PMC1565667", "9846641"]}, {"Citation": "Tikellis C., Thomas M.C. Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. Int. J. Pept. 2012;2012:256294. doi: 10.1155/2012/256294.", "ArticleIdList": ["10.1155/2012/256294", "PMC3321295", "22536270"]}, {"Citation": "Ferrario C.M., Trask A.J., Jessup J.A. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am. J. Physiol. Heart Circ. Physiol. 2005;289:H2281\u2013H2290. doi: 10.1152/ajpheart.00618.2005.", "ArticleIdList": ["10.1152/ajpheart.00618.2005", "PMC7203566", "16055515"]}, {"Citation": "Sanchis-Gomar F., Lavie C.J., Perez-Quilis C., Henry B.M., Lippi G. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Mayo Clin. Proc. 2020;95:1222\u20131230. doi: 10.1016/j.mayocp.2020.03.026.", "ArticleIdList": ["10.1016/j.mayocp.2020.03.026", "PMC7129862", "32376099"]}, {"Citation": "Zores F., Rebeaud M.E. COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious? Front. Cardiovasc. Med. 2020;7:71. doi: 10.3389/fcvm.2020.00071.", "ArticleIdList": ["10.3389/fcvm.2020.00071", "PMC7191060", "32391384"]}, {"Citation": "Sienko J., Kotowski M., Bogacz A., Lechowicz K., Drozdzal S., Rosik J., Sietnicki M., Sienko M., Kotfis K. COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients. Clin. Interv. Aging. 2020;15:1231\u20131240. doi: 10.2147/CIA.S261516.", "ArticleIdList": ["10.2147/CIA.S261516", "PMC7382582", "32764907"]}, {"Citation": "Pan Y., Wang T., Li Y., Guan T., Lai Y., Shen Y., Zeyaweiding A., Maimaiti T., Li F., Zhao H., et al. Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China. Lipids Health Dis. 2018;17:241. doi: 10.1186/s12944-018-0890-6.", "ArticleIdList": ["10.1186/s12944-018-0890-6", "PMC6195726", "30342552"]}, {"Citation": "Zhang Q., Cong M., Wang N., Li X., Zhang H., Zhang K., Jin M., Wu N., Qiu C., Li J. Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender: A case-control study. Medicine. 2018;97:e12917. doi: 10.1097/MD.0000000000012917.", "ArticleIdList": ["10.1097/MD.0000000000012917", "PMC6211892", "30335025"]}, {"Citation": "Lieb W., Graf J., Gotz A., Konig I.R., Mayer B., Fischer M., Stritzke J., Hengstenberg C., Holmer S.R., Doring A., et al. Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J. Mol. Med. 2006;84:88\u201396. doi: 10.1007/s00109-005-0718-5.", "ArticleIdList": ["10.1007/s00109-005-0718-5", "16283142"]}, {"Citation": "Barash A., Machluf Y., Ariel I., Dekel Y. The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences. Front. Med. 2020;7:582793. doi: 10.3389/fmed.2020.582793.", "ArticleIdList": ["10.3389/fmed.2020.582793", "PMC7661736", "33195331"]}, {"Citation": "Gemmati D., Tisato V. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19. Genes. 2020;11:1044. doi: 10.3390/genes11091044.", "ArticleIdList": ["10.3390/genes11091044", "PMC7563402", "32899439"]}, {"Citation": "Patel S.K., Velkoska E., Freeman M., Wai B., Lancefield T.F., Burrell L.M. From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension. Front. Physiol. 2014;5:227. doi: 10.3389/fphys.2014.00227.", "ArticleIdList": ["10.3389/fphys.2014.00227", "PMC4067757", "25009501"]}, {"Citation": "Pouladi N., Abdolahi S. Investigating the ACE2 polymorphisms in COVID-19 susceptibility: An in silico analysis. Mol. Genet. Genomic. Med. 2021;9:e1672. doi: 10.1002/mgg3.1672.", "ArticleIdList": ["10.1002/mgg3.1672", "PMC8222831", "33818000"]}, {"Citation": "Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020;17:259\u2013260. doi: 10.1038/s41569-020-0360-5.", "ArticleIdList": ["10.1038/s41569-020-0360-5", "PMC7095524", "32139904"]}, {"Citation": "Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q., Ji R., Wang H., Wang Y., Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020;94:91\u201395. doi: 10.1016/j.ijid.2020.03.017.", "ArticleIdList": ["10.1016/j.ijid.2020.03.017", "PMC7194638", "32173574"]}, {"Citation": "Cafiero C., Rosapepe F., Palmirotta R., Re A., Ottaiano M.P., Benincasa G., Perone R., Varriale E., D\u2019Amato G., Cacciamani A., et al. Angiotensin System Polymorphisms\u2019 in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study. Pharmgenomics Pers. Med. 2021;14:621\u2013629. doi: 10.2147/PGPM.S303666.", "ArticleIdList": ["10.2147/PGPM.S303666", "PMC8166347", "34079337"]}, {"Citation": "Hamet P., Pausova Z., Attaoua R., Hishmih C., Haloui M., Shin J., Paus T., Abrahamowicz M., Gaudet D., Santucci L., et al. SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking. Am. J. Hypertens. 2021;34:367\u2013376. doi: 10.1093/ajh/hpaa223.", "ArticleIdList": ["10.1093/ajh/hpaa223", "PMC7799248", "33386398"]}, {"Citation": "Fan Z., Wu G., Yue M., Ye J., Chen Y., Xu B., Shu Z., Zhu J., Lu N., Tan X. Hypertension and hypertensive left ventricular hypertrophy are associated with ACE2 genetic polymorphism. Life Sci. 2019;225:39\u201345. doi: 10.1016/j.lfs.2019.03.059.", "ArticleIdList": ["10.1016/j.lfs.2019.03.059", "30917908"]}, {"Citation": "Mohlendick B., Schonfelder K., Breuckmann K., Elsner C., Babel N., Balfanz P., Dahl E., Dreher M., Fistera D., Herbstreit F., et al. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19. Pharm. Genomics. 2021;31:165\u2013171. doi: 10.1097/FPC.0000000000000436.", "ArticleIdList": ["10.1097/FPC.0000000000000436", "PMC8415730", "34001841"]}, {"Citation": "Gomez J., Albaiceta G.M., Garcia-Clemente M., Lopez-Larrea C., Amado-Rodriguez L., Lopez-Alonso I., Hermida T., Enriquez A.I., Herrero P., Melon S., et al. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene. 2020;762:145102. doi: 10.1016/j.gene.2020.145102.", "ArticleIdList": ["10.1016/j.gene.2020.145102", "PMC7456966", "32882331"]}, {"Citation": "Liu C., Li Y., Guan T., Lai Y., Shen Y., Zeyaweiding A., Zhao H., Li F., Maimaiti T. ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus. Cardiovasc. Diabetol. 2018;17:127. doi: 10.1186/s12933-018-0771-3.", "ArticleIdList": ["10.1186/s12933-018-0771-3", "PMC6142339", "30227878"]}, {"Citation": "Sze S., Pan D., Nevill C.R., Gray L.J., Martin C.A., Nazareth J., Minhas J.S., Divall P., Khunti K., Abrams K.R., et al. Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. eClinicalMedicine. 2020;29:100630. doi: 10.1016/j.eclinm.2020.100630.", "ArticleIdList": ["10.1016/j.eclinm.2020.100630", "PMC7658622", "33200120"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "18"}, {"Year": "2022", "Month": "9", "Day": "23"}, {"Year": "2022", "Month": "9", "Day": "29"}, {"Year": "2022", "Month": "10", "Day": "14", "Hour": "2", "Minute": "2"}, {"Year": "2022", "Month": "10", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["36231922", "PMC9564490", "10.3390/ijerph191912622", "ijerph191912622"]}}], "PubmedBookArticle": []}